v3.25.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash Flows from Operating Activities    
Net loss $ (3,616) $ (3,576)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 872 1,018
Depreciation and amortization 42 100
Provision for credit losses on accounts receivable 10
Amortization of operating right-of-use asset 65 60
Increase (decrease) in cash resulting from changes in:    
Accounts receivable (23) (63)
Inventory 11 (78)
Prepaid expenses and other assets 20 29
Accounts payable 127 (167)
Accrued expenses 87 390
Operating lease liability (68) (61)
Net cash used in operating activities (2,483) (2,338)
Cash Flows from Investing Activities    
Purchases of property and equipment (119)
Net cash used in investing activities (119)
Cash Flows from Financing Activities    
Gross proceeds from issuance of common stock, prefunded warrants and warrants 4,010
Gross proceeds from issuance of common stock, prefunded warrants and warrants under inducement agreement 3,057
Proceeds from issuance of Series A convertible preferred stock 2,605
Proceeds from issuance of common stock 1,990
Offering costs (808) (224)
Net cash provided by financing activities 6,259 4,371
Effect of foreign currency translation on cash flow 46
Net Increase in Cash and Cash Equivalents 3,776 1,960
Cash and Cash Equivalents at Beginning of Period 6,535 2,428
Cash and Cash Equivalents at End of Period 10,311 4,388
Non-cash investing and financing activities:    
Warrant modification costs 1,402
Preferred stock issued upon conversion of debt and accrued interest 1,186
Reclassification of deferred offering costs to additional paid-in capital $ 110 $ 130